Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vantictumab Placed on Partial Clinical Hold by FDA Following Voluntary Halt by OncoMed
Vantictumab Placed on Partial Clinical Hold by FDA Following Voluntary Halt by OncoMed
Vantictumab Placed on Partial Clinical Hold by FDA Following Voluntary Halt by OncoMed
Submitted by
admin
on June 14, 2014 - 9:22am
Source:
Yahoo/Globe Newswire
News Tags:
vantictumab
OncoMed
Headline:
Vantictumab Placed on Partial Clinical Hold by FDA Following Voluntary Halt by OncoMed
Do Not Allow Advertisers to Use My Personal information
